Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
23
CATX Quote, Financials, Valuation and Earnings
Last price:
$2.87
Seasonality move
:
41.25%
Day range:
$2.80 - $2.96
52-week range:
$2.70 - $19.05
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
15.39x
P/B ratio:
0.59x
Volume:
2.9M
Avg. volume:
2.3M
1-year change:
-16.67%
Market cap:
$192.6M
Revenue:
--
EPS (TTM):
-$1.46
CATX Analysts' Consensus Rating
The 0 analysts providing 12-month price projections for Perspective Therapeutics shares anticipate an average target of --, ranging from a low estimate of -- to a high estimate of --. This average target implies a growth of 466.67% compared to the current stock price of $2.85.
Consensus Price Target
--
Highest Price Target
--
Lowest Price Target
--
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Analyst Ratings
| 6M Ago | 1M Ago | Current | |
|---|---|---|---|
| Buy | 5 | 8 | 0 |
| Hold | 0 | 1 | 0 |
| Sell | 0 | 0 | 0 |
| Consensus | Buy | Buy | Buy |
CATX Recommendation Trends
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
